Highlights from day 4 #AACR26: Brian Liau about the structural convergence between a KBTBD4 glue & cancer associated mutations; Amphista’s targeted BRD9 glue degrader; Cycle Pharma’s 1st disclosure of a cyclin A/B inhibitor; poster session breaks w/ MSD’s cinnamon sugar churros.